Literature DB >> 11523083

Statistical issues in bioequivalence [correction of bioequivalance].

S Senn1.   

Abstract

There has been much work recently on individual bioequivalence and the topic has attracted considerable controversy. Some previous controversies regarding average bioequivalence are examined. It is argued that a contributory factor in these controversies may have been confusion over the purpose of bioequivalence trials. It is concluded that this purpose needs further clarification before guidelines for individual bioequivalence can be established and indeed that such guidelines may turn out to be unnecessary. Copyright 2001 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2001        PMID: 11523083     DOI: 10.1002/sim.743

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Limits for the scaled average bioequivalence of highly variable drugs and drug products.

Authors:  Laszlo Tothfalusi; Laszlo Endrenyi
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

2.  The Controversy over Generic Antiepileptic Drugs.

Authors:  Susan J Shaw; Adam L Hartman
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

3.  Bioequivalence testing by statistical shape analysis.

Authors:  Luis Marcelo Pereira
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-07       Impact factor: 2.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.